https://www.medscape.com/viewarticle/996136
0
0
9/18/23 at 2:40pm
Organization
Medscape
32 words
0
Comments
Thomas Ciulla, MD, discusses the clinical transition from therapeutically limited laser-based therapies to the introduction of anti-VEGF drugs.
You are the first to view
Create an account
or login to join the discussion